VIDEO: Top priorities for the Medical Group Management Association in 2022

Amy Baxter | | Health Exec | Policy & Regulations

 

Pending Medicare payment cuts were the big news toward the end of 2022, and staving off the hurt from those cuts has become a top priority for the Medical Group Management Association (MGMA), Claire Ernst told Health Exec.

Ernst is the director of government affairs at MGMA, and she told Health Exec what was top of mind for MGMA this year. The group has also been carefully tracking what the end of the public health emergency (PHE) could mean for healthcare providers. The PHE was put in place at the beginning of the pandemic and has been renewed every 90 days ever since. It provides many flexibilities for healthcare providers to meet the demands during the pandemic. When it ends, many care providers will have to make adjustments to their care services, and millions of Americans will lose their eligibility for Medicaid.

[VIDEO: MGMA explains why the COVID-19 public health emergency extension is critical]

In addition, MGMA has been focused on prior authorization, with their membership stating the burdens associated with prior authorization have increased as of late. Ernst's comments came before the Centers for Medicare and Medicaid Services (CMS) published a proposed rule to streamline prior authorization and modernize the system.

See the video to hear all of MGMA's priorities.

Related Content

Millions will lose Medicaid coverage when COVID-19 PHE ends
CMS proposes rule on prior authorization
PHE for COVID-19 will continue past January
Providers face ‘ominous reality’ of payment cuts as CMS finalizes 2023 Physician Fee Schedule
VIDEO: MGMA explains why the COVID-19 public health emergency extension is critical
Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”